Doctor profile · Federal record

Dr. Cherish Holt, APN-BC

Nurse Practitioner · Nashville, TN

  • NPI 1659703817
  • Accepts Medicare
  • 14 yrs in practice
  • Female
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
330 23Rd Ave N Ste 500
Nashville, TN 37203
(615) 342-5900
fax (615) 342-7863

Credentials & registration

NPPES · NUCC
NPI registered
July 2013 — 13 yrs on file
Profile last updated
October 1, 2018
Year of graduation
2012 — 14 yrs since
Specialty taxonomy
363L00000X — NUCC code
State license (1)
Tennessee #17831

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1659703817. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
227
Distinct HCPCS
4
Medicare allowed
$16,312
HCPCS Description Services Patients Avg allowed
99214 Established patient office or other outpatient visit, 30-39 minutes 130 101 $99
95251 Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report 72 56 $27
82962 Blood glucose (sugar) test performed by hand-held instrument 14 13 $3
99204 New patient office or other outpatient visit, 45-59 minutes 11 11 $131

In context: peer comparison

Among 57 peers in Nashville Nurse Practitioner, average services per provider: 155. This provider delivers 1.5× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$4,079
Transactions
148
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Novo Nordisk INC 27 $623.43
CeQur Corporation 1 $482.06
Beta Bionics, INC. 14 $470.62
Lilly USA, LLC 21 $444.70
Abbott Laboratories 15 $295.31
Amgen INC. 14 $250.60
Xeris Pharmaceuticals, INC. 9 $179.38
Corcept Therapeutics 7 $167.84
Insulet Corporation 8 $160.50
Sanofi-Aventis U.S. LLC 9 $159.57
Boehringer Ingelheim Pharmaceuticals, INC. 8 $134.02
Tandem Diabetes Care, INC. 5 $130.44
Dexcom, INC. 3 $96.81
Alexion Pharmaceuticals, INC. 4 $78.37
Mannkind Corporation 3 $62.89

By nature of payment

Food and Beverage
$4,079

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
783
Patients
242
Total drug cost
$774,045
Drug Type Claims Patients Total cost
Ozempic (Semaglutide) Brand 121 39 $196,865
Nano 2Nd Gen Pen Needle (Pen Needle, Diabetic) Brand 76 32 $10,418
Novolog Flexpen (Insulin Aspart) Brand 74 21 $99,397
Levothyroxine Sodium Generic 65 29 $1,161
Tresiba Flextouch U-100 (Insulin Degludec) Brand 59 21 $55,697
Tresiba Flextouch U-200 (Insulin Degludec) Brand 59 15 $100,239
Trulicity (Dulaglutide) Brand 49 0 $67,540
Mounjaro (Tirzepatide) Brand 48 19 $63,326
Metformin Hcl Generic 47 21 $400
Lantus Solostar (Insulin Glargine,Hum.Rec.Anlog) Brand 41 13 $33,303

Frequently asked questions

Auto-generated from federal data
What is Dr. Cherish Holt's medical specialty?
Dr. Cherish Holt practices Nurse Practitioner in Nashville, TN.
Where does Dr. Cherish Holt practice?
Dr. Cherish Holt practices at 330 23Rd Ave N Ste 500, Nashville, TN 37203. Office phone: 6153425900.
What is Dr. Cherish Holt's NPI?
Dr. Cherish Holt's National Provider Identifier (NPI) is 1659703817, issued by NPPES.
Does Dr. Cherish Holt accept Medicare assignment?
Yes. Dr. Cherish Holt accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Cherish Holt commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99214); Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report (HCPCS 95251); Blood glucose (sugar) test performed by hand-held instrument (HCPCS 82962). Source: CMS Medicare Physician & Other Practitioners file.